AmCAD-UO

by AmCad BioMed Corporation  · Based in Taiwan → — Pioneering Ultrasound AI The Future of Ultrasound Imaging is Here
Otolaryngology (ENT) Radiology Sleep Medicine

Regulatory Status Disclosed

Overview

AmCAD-UO is an innovative, AI-powered ultrasound solution developed by AmCad BioMed Corporation, designed to assist physicians in the evaluation and monitoring of Obstructive Sleep Apnea (OSA) syndrome. The system comprises a precise positioning system and a computer-assisted detection (CAD) software device. The software then automatically detects the airspace of the pharyngeal airway and computes dynamic changes to assess the risk of OSA. This non-invasive evaluation process is performed on awake patients and delivers results in approximately 10 minutes, offering an objective, accurate, cost-effective, and safe approach to OSA diagnosis.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered ultrasound analysis for Obstructive Sleep Apnea (OSA)
  • Non-invasive upper airway scanning
  • Computer-assisted detection (CAD) software
  • Automatic detection of pharyngeal airway airspace
  • Dynamic change computation of airspace for OSA risk evaluation
  • 10-minute assessment on awake patients
  • Objective, accurate, cost-effective, and safe evaluation process
  • Laser-guided positioning for precise scanning
  • 3D anatomic airway assessment
  • Standardizes ultrasound transducer scanning to reduce intra-observer variations

Use Cases

  • Evaluating the risk of Obstructive Sleep Apnea (OSA) syndrome
  • Assessing moderate/severe OSA patients
  • Identifying the root cause of sleep apnea
  • Evaluating patients for tongue reduction surgery (ENT)
  • Assessing the effectiveness of oral appliances in dentistry
  • Precision treatment and follow-up in clinical settings for OSA

What Physicians Need to Know

Supported Modalities
Ultrasound (US)
AI Model Architecture (deep learning approach)
AmCAD-UO utilizes AI for sub-mental ultrasound scanning and detection to enhance the accuracy of Obstructive Sleep Apnea (OSA) assessment. The AI analyzes upper airway regions (velum, oropharynx, tongue base, epiglottis) to identify potential sites of collapse. It uses deep learning techniques for image interpretation. The specific deep learning model architectures evaluated in similar contexts include MobileNetV2 and DarkNet53, and convolutional neural networks (CNNs) are a common approach for image analysis in deep learning.
Processing Speed (per study)
The AmCAD-UO system can perform an ultrasound scan and provide OSA risk results in approximately 10 minutes per patient.
FDA Clearance Pathway (510k/De Novo)
AmCAD-UO received FDA 510(k) clearance in December 2018. It is also CE marked.
Sensitivity & Specificity Data
In a study involving 1101 individuals, the positive predictive values (PPVs) for participants with mild, moderate, and severe OSA were 94.8%, 87.6%, and 72.2%, respectively. For a high-risk group, the PPV was 94.8%, and for moderate-to-severe OSA (AHI≥15), the PPV was 72.2%. Another study showed that AmCAD-UO achieved nearly 80% accuracy in predicting suitable patients for hypoglossal nerve stimulation (HNS) therapy.
DICOM Support & Standards
AmCAD-UO is compatible with all ultrasound systems, and images are transferred from the ultrasound machine to a Windows-based computer for analysis. While not explicitly stated for AmCAD-UO, AmCAD BioMed's other products, such as AmCAD-UT, analyze DICOM files and are PACS compatible, suggesting a general adherence to DICOM standards within the company's product line. DICOM is the international standard for managing medical images, including ultrasound (US) modality.
PACS Integration Method
Images are transferred from the ultrasound machine to a Windows-based computer for analysis. The system then generates a detection report. AmCAD BioMed's other products are noted to integrate into radiology workstations and interface with PACS, indicating a capability for PACS integration across their solutions.
Reading Room Workflow Impact
AmCAD-UO offers a quick, 10-minute AI-powered screening for OSA in awake patients, aiming to provide a non-invasive, fast, and patient-friendly alternative to traditional polysomnography. This can potentially streamline the initial assessment of OSA and reduce the burden on sleep centers. The system generates a detection report to facilitate assessment. AI tools in general can help reduce interruptions in the reading room by handling non-image interpretation tasks.
Physician Tip

AmCAD-UO provides a rapid, non-invasive ultrasound-based assessment for Obstructive Sleep Apnea (OSA) in awake patients, offering a valuable screening tool to identify at-risk individuals. The AI-powered analysis helps pinpoint potential collapse areas in the upper airway, providing objective measurements. This can be particularly useful for initial risk assessment, monitoring treatment progress, and in settings where traditional polysomnography is not readily available or feasible. The system's ability to provide consistent, trackable evaluations through laser-guided positioning can aid in longitudinal patient management. It can also assist in predicting the suitability of patients for certain therapies like hypoglossal nerve stimulation.

The AmCAD-UO system is compatible with all ultrasound systems, transferring images to a Windows-based computer for AI analysis and report generation. While direct PACS integration details for AmCAD-UO are not explicitly detailed, AmCAD BioMed's other AI solutions are designed to integrate with radiology workstations and PACS, suggesting a similar capability or potential for AmCAD-UO. The system's output of a detection report can be incorporated into existing electronic health record systems.

Details

Category Radiology & Imaging AI
Pricing Unknown
DeploymentPC based, self contained system; Images are transferred from the ultrasound machine to a Windows-based computer for analysis.
Compliance
BAA AvailableUnknown
HIPAA CompliantUnknown
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Otolaryngology (ENT), Radiology, Sleep Medicine

FDA clearance history

This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.

Decision dateNumberName as listed by FDA
2018-12-28K180867 510(k)AmCAD-UO

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate AmCAD-UO

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for AmCAD-UO.

View all on YouTube

Frequently Asked Questions

AmCAD-UO is an AI-powered ultrasound solution that provides a fast and comfortable 10-minute screening for OSA. It objectively measures upper airway structures and uses AI to identify potential collapse regions, helping clinicians assess risk and determine next steps. The system can also track treatment progress by capturing consistent ultrasound images across sessions.
AmCAD-UO offers objective, consistent, and trackable evaluation of the upper airway. It helps identify potential sites of collapse using AI analysis of regions like the velum, oropharynx, tongue base, and epiglottis. This allows for personalized treatment decisions, preoperative evaluations, and postoperative tracking, enhancing clinical versatility.
While AmCAD-UO provides valuable data for evaluation and monitoring, it is not intended for use alone for primary diagnostic interpretation. It complements existing methods by offering a quick, awake ultrasound scan that can help identify the root cause of sleep apnea and assess moderate to severe OSA patients. It can also be used to evaluate the effectiveness of CPAP alternatives or to assess patients for surgical interventions.
Traditional methods for OSA detection include polysomnography (PSG), which often requires overnight testing and can have long wait times. Other treatment options for OSA include continuous positive airway pressure (CPAP), mandibular advancement devices (MAD), nasal expiratory airway pressure devices, hypoglossal nerve stimulators, and oral pressure therapy. AmCAD-UO offers a non-invasive, awake, and quick alternative for initial assessment and monitoring.
AmCAD-UO was cleared by the United States Food and Drug Administration (FDA) in December 2018 to provide data for a physician's evaluation and monitoring of patients' airways. It is designed to assist physicians in evaluating the risk of OSA and is not meant for standalone primary diagnostic interpretation.
AmCAD-UO utilizes AI to automatically analyze images and provide standardized metrics, aiming for objective and consistent measurements. While AI in radiology raises concerns about potential bias or errors, AmCAD BioMed focuses on enhancing diagnostic accuracy and streamlining workflows. The system's laser-guided robotic arm helps reduce intra-observer variations, contributing to more consistent assessments.
To obtain pricing information or a quote for the AmCAD-UO system, you would need to contact AmCad BioMed directly or one of their suppliers.

Related Tools

RADIN Health
RADIN Health
Clinical Decision Support & Reference
RADINA is an AI-powered platform by RADIN Health designed to optimize radiology workflows, enhance diagnostic accuracy, and streamline reporting.
VERITON CT 400 Series Digital SPECT/CT System (VERITON CT 416/464)
Spectrum Dynamics Medical
Oncology AI
The VERITON CT 400 Series is a digital SPECT/CT system with a 360-degree gantry and 12 swiveling CZT detectors, offering high sensitivity and quantitative accuracy for a wide range of nuclear medicine applications, including advanced theranostics imaging.
VERITON CT 300 Series Digital SPECT/CT System (VERITON CT 316/364)
Spectrum Dynamics Medical
Radiology & Imaging AI
The VERITON-CT 300 Series Digital SPECT/CT System is a new-generation SPECT/CT system that wraps 360° around the patient's body contour for a personalized exam, utilizing 12 digital CZT detectors for accurate and confident diagnoses.
ACUSON Sequoia Diagnostic Ultrasound System, ACUSON Sequoia Select Diagnostic Ultrasound System, ACUSON Origin Diagnostic Ultrasound System, ACUSON Origin ICE Diagnostic Ultrasound System
Siemens Medical Solutions, USA
Cardiology AI
Siemens Healthineers offers advanced AI-powered ultrasound systems, including the ACUSON Origin for comprehensive cardiovascular care and the ACUSON Sequoia for high-performance general imaging with BioAcoustic™ technology.
syngo.via MI Workflows, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, syngo MBF is an intelligent, integrated imaging software that helps address the challenges of interpreting, managing, and sharing complex data from molecular imaging scanners, providing automated workflows and advanced visualization for various clinical applications.
MAGNETOM Vida, MAGNETOM Sola, MAGNETOM Lumina, MAGNETOM Altea
Siemens Medical Solutions USA
Radiology & Imaging AI
Siemens Medical Solutions USA, Inc. provides innovative medical technologies and services that enhance healthcare delivery, specializing in advanced medical imaging systems like the MAGNETOM MRI series.

See all Radiology & Imaging AI tools →

More from AmCad BioMed

AmCAD-UT
AmCad BioMed Corporation
Endocrinology & Metabolic AI
AmCAD-UV
AmCad BioMed
Cardiology AI
AmCAD-UV is an AI-powered ultrasound software device for vascular pulsatility analysis, quantifying and classifying ultrasonic color intensity data to assist in interpreting hemodynamic variations in blood vessels.

View company profile →

Suggest an Edit → | Report an issue | Last Verified: 2026-10-14 | First Added: 2026-04-17
AI Tool Finder
AI-powered search. Results may not be comprehensive.